Browse drugs

…ed, with MACE risk peaking at 6–8 canisters annually.Conclusion SABA overuse (≥3 canisters/year) is associated with increased risks …

…Introduction In the UK, short-acting β2-agonist (SABA) overuse in asthma remains common; however, this treatment stra…

…eview found low-to-moderate certainty evidence that intravenous SABA would improve acute asthma severity with infrequent adverse eve…

…first: −0.1% (SD 0.03%) per month, p=0.001 vs AIR; and ICS plus SABA: −0.16% (SD 0.06%) per month, p=0.004, vs AIR). Therefore, regi…

…eceive an anti-inflammatory reliever on discharge as part of an AIR/MART inhaler regimen.…

… as needed to relieve symptoms (most commonly relievers contain salbutamol). This strategy is vulnerable to poor adherence to maintenance …

…talisations. This trial will bridge the gap for the efficacy of budesonide/formoterol in children <12 years of age and address the economic arguments…

…seline characteristics and main outcomes of patients initiating BGF after dual therapyConclusion In the ORESTES study conducted in …

… (AIR) therapies that combine inhaled corticosteroids (ICS) and formoterol for newly diagnosed asthma and patients treated with SABA only.…

…ence of allergy diagnosis (52.5% vs 53.6%). Patients prescribed msBDP/FF/G were older than those prescribed hsICS/LABA (mean±standard devi…

…ultiple stakeholders in the ICB.This resulted in a reduction in SABA-only prescribing, and an increase in MART. Implementing guideline re…

… 0/44 (0.0%) 0/44 (0.0%) NA 50/230 (21.7%) 36/141 (25.5%) 0.475 Omalizumab NA NA NA 0/44 (0.0%) 0/44 (0.0%) NA 36/236 (15.3%) 16/141 (11.3…